1 study on VIBRIOGUARD-12 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights the potential of chirality-converted bacteriolytic peptides as a promising new class of antimicrobials that can effectively target pathogens without causing widespread disruption to beneficial…